Share This

Public company info - Ascentage Pharma Group International , 06855.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Ascentage Pharma Group International, 06855.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12
Net Cash Flow from Operating Activities -653,915 -600,833 -609,956 -460,305 -237,667 -107,985 -45,893
Net Cash Flow from Return on Investments & Servicing of Finance -49,849 -16,808 -5,935 -4,268 -1,892 -257 -49
　Interest Received 0 0 0 0 0 0 0
　Interest Paid -49,849 -16,808 -5,935 -4,268 -1,892 -257 -49
　Dividend Received 0 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 -3,846 0 0 0 0 0
Net Cash Flow from Investing Activities -384,612 -466,522 -107,367 -201,333 292,808 -230,347 -152,611
　Additions to Fixed Assets -203,288 -435,415 -249,921 -77,456 -14,257 -20,536 -3,285
　Disposal of Fixed Assets 2,351 335 0 0 2 13 7
　Increase in Investments -20,000 -1,820,016 -2,170,111 -1,806,601 342,266 -209,824 -149,247
　Decrease in Investments 0 1,789,788 2,174,696 1,826,208 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0
　Others -163,675 -1,214 137,969 -143,484 -35,203 0 -86
Net Cash Flow before Financing Activities -1,088,376 -1,088,009 -723,258 -665,906 53,249 -338,589 -198,553
Net Cash Flow from Financing Activities 669,117 1,798,195 1,045,938 446,630 862,055 58,619 435,584
　New Loans 763,617 599,737 527,805 85,000 85,000 0 0
　Loans Repayment -67,743 -60,242 -102,670 -42,660 -53,339 -2,274 -532
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Equity Financing 19 1,284,574 620,803 404,290 910,616 60,893 436,116
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0
　Others -26,776 -25,874 0 0 -80,222 0 0
Increase(Decrease) in Cash & Cash Equivalents -419,259 710,186 322,680 -219,276 915,304 -279,970 237,031
Cash & Cash Equivalents at Beginning of Year 1,706,886 1,019,979 738,986 957,088 14,821 294,529 57,602
Net Cash Flow due to Change in Exchange Rate/Others 58,012 -23,279 -41,687 1,174 26,963 262 -104
Cash & Cash Equivalents at End of Year 1,345,639 1,706,886 1,019,979 738,986 957,088 14,821 294,529
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.